Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors

Sustained cardiac hypertrophy represents one of the most common causes leading to cardiac failure. There is emerging evidence to implicate the involvement of NF-κB in the development of cardiac hypertrophy. However, several critical questions remain unanswered. We tested the use of soluble epoxide h...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xu, Danyan, Li, Ning, He, Yuxia, Timofeyev, Valeriy, Lu, Ling, Tsai, Hsing-Ju, Kim, In-Hae, Tuteja, Dipika, Mateo, Robertino Karlo P., Singapuri, Anil, Davis, Benjamin B., Low, Reginald, Hammock, Bruce D., Chiamvimonvat, Nipavan
Formato: Artigo
Lenguaje:Inglês
Publicado: National Academy of Sciences 2006
Materias:
Biological Sciences
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1693731/
https://ncbi.nlm.nih.gov/pubmed/17130447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0609158103
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares